News
3d
GardenTabs on MSNHow To Grow Geraniums [Care Tips, Pictures And More]Geraniums prefer a warm, dry environment and thus may not survive on an exposed, cold porch. However, they could potentially ...
Kendy Howard, a 48-year-old wife and mother, was found dead in her bathtub with a gunshot wound to the head. Evidence at the scene led investigators to take a hard look at her husband, a former Idaho ...
Eye diseases are not uncommon. They can affect anyone, especially as you age. Many people don’t notice symptoms until their vision is already at risk. As to global statistics, nearly two out of ...
Learn about eye changes that could indicate serious health conditions, from blurry vision to persistent floaters and flashes ...
High blood sugars have long been known to cause eye damage in diabetics. However, new research has found that low blood sugar ...
Beacon Therapeutics may have found a guiding light in a disease area where other companies have stumbled with its ...
2d
News-Medical.Net on MSNLow blood sugar linked to retinal damage in diabetic eye diseaseIn a new National Institutes of Health-funded study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine ...
eye conditions. People spend a lot of time on their electronic devices, which emit blue light, and experience blue light exposure from the sun. Most researchers believe that the blue light from ...
A Recently Completed Dry Eye Disease Field Trial, which Was Numerically Supportive of Reproxalap and Consistent with Prior Field Trials, Did Not Reach Statistical Significance, and Is Expected to ...
In cases with optic nerve hyperfluorescence or neurologic symptoms, prompt neuroimaging is warranted to rule out neuro-Behcet ...
Reproxalap is an investigational new drug candidate in development for the treatment of dry eye disease and allergic conjunctivitis, two of the largest markets in ophthalmology. Reproxalap is a ...
The treatment failed to improve the vision-guided mobility of patients with the eye disease X-linked retinitis pigmentosa (XLRP) in a phase 3 trial, according to results shared May 2. The LUMEOS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results